CoroWare, Inc.
Founding members bring decades of management and technology leadership
OXFORD, ENGLAND and WOODINVILLE, WA / ACCESSWIRE / October 26, 2021 / CoroWare (OTC PINK:COWI) today announced that CarbonMeta Research Ltd, a wholly owned subsidiary of CoroWare that is based in Oxford, England, appointed Tiancun Xiao and Mohammed Khalil to the subsidiary's Board of Directors.
Dr. Xiao is a Senior Research Fellow at University of Oxford, has contributed to the development of novel catalysts and corresponding process for microwave assisted catalysis, which can selectively break C-H or C-C bond in hydrocarbons, including natural gas, liquid hydrocarbon, wax and polymers such as polyethylene, polypropylene, polystyrene and tyres. Dr Xiao has rich experiences in commercializing patent and transferring to industrial operation. He co-founded Oxford Catalyst Ltd in 2004, now rebranded as Velocys. He is also a co-founder of OxCCU Tech Ltd, a spinout company from Oxford University focusing on thermally catalysis in converting CO2 into aviation fuel or valuable chemicals.
Mr. Khalil is the co-founder of EcoMENA, an award-winning environmental platform that fosters sustainability, waste management and renewable energy in the Middle East and North Africa region. Mr. Khalil is also the Director and Co-Founder of Fusor Tech, an additive manufacturing company based in the England that is focused on producing advanced metal parts and additive manufacturing technologies for the space, oil & gas, marine and medical industries.
"I could not be more excited to welcome and announce the appointments of Mr. Khalil and Dr. Xiao to the Board of Directors of CarbonMeta Research," said Lloyd Spencer, Chairman and CEO of CoroWare., "They bring decades of leadership in key areas such as strategy implementation, technology development, and operational management, all of which will be vital to the success of CarbonMeta Research and CoroWare."
Mr. Khalil will serve as Managing Director, Dr. Xiao will serve as Chief Technology Officer, and Mr. Spencer will serve as Chairman of the Board of Directors of CarbonMeta Research Ltd.
About CarbonMeta Research Ltd.
CarbonMeta Research Ltd. is a wholly owned subsidiary of CoroWare that is based in the United Kingdom, and whose focus will be on the development of technologies and solutions for processing organic wastes and generating economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.carbonmetaresearch.co.uk.
About CoroWare Inc.
CoroWare Inc. (OTC PINK:COWI), headquartered in Woodinville, Washington, is in the early stage of transitioning into a resource reclamation company that will process organic wastes and generate economically sustainable hydrogen and high-value carbon products.
For more information about the company, please visit www.CoroWare.com.
Forward-Looking Statement
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The ability of the Company to complete and file its Fiscal Year 2016 annual report on Form 10K relies on third parties to complete their activities. Investors are cautioned that such forward-looking statements involve risks and uncertainties, which include among others, the inherent uncertainties associated with smaller reporting companies, including without limitation, other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
CONTACT INFORMATION
Mark Duiker
CoroWare Investor Relations
(844) 641-2676, option 3
Investor@CoroWare.com
SOURCE: CoroWare, Inc.
View source version on accesswire.com:
https://www.accesswire.com/669384/CoroWare-Subsidiary-CarbonMeta-Research-Ltd-Appoints-Board-of-Director-Members
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
eComplete Partners with Sourceful to build AI-Native Creative Operations Across Portfolio18.11.2025 15:00:00 CET | Press release
MANCHESTER, UK / ACCESS Newswire / November 18, 2025 / eComplete, the private equity firm behind Current Body's £300 million London Stock Exchange listing, has announced a strategic partnership with Sourceful, the Manchester-based technology company whose Riverflow 1 model ranks as the world's leading AI image editing model. The partnership brings Sourceful's AI-native creative platform to eComplete's portfolio of direct-to-consumer brands, enabling them to generate brand-accurate, production-ready creative assets at scale across e-commerce, social, marketplace and retail. This makes eComplete the first major private equity investor to adopt AI-native creative infrastructure as a core operational advantage. Why this matters Every consumer brand today faces the same constraint: producing thousands of creative assets, product images, ads, videos, packaging, that feel authentically on-brand across every channel and market. This challenge has intensified dramatically over the past three ye
IXOPAY Appoints George Hansen as Chief Revenue Officer to Accelerate Global Growth in Tokenization, Orchestration, and Compliance18.11.2025 06:00:00 CET | Press release
Seasoned payments executive joins IXOPAY to lead global revenue strategy amid rapid growth and the rise of agentic commerce. LEHI, UTAH / ACCESS Newswire / November 18, 2025 / IXOPAY, a global leader in enterprise-grade payment orchestration, today announced the appointment of George Hansen as Chief Revenue Officer (CRO). A veteran of the payments and fintech industries, Hansen brings more than two decades of leadership experience driving growth, transformation, and customer-centric innovation at a global scale. In his new role, Hansen will drive IXOPAY's global revenue strategy, leading sales and partnerships and aligning with marketing and customer success to support enterprise merchants and partners worldwide. His appointment reinforces IXOPAY's commitment to giving merchants full control of their payment strategy through a vendor-neutral architecture designed for scale, flexibility, and intelligence. Hansen has held senior leadership positions at companies including American Expres
General Holdings Limited and NewOak Capital Form Strategic Joint Venture to Launch CMXG, an $800M Commodities Investment Platform18.11.2025 06:00:00 CET | Press release
DUBAI, AE / ACCESS Newswire / November 18, 2025 / General Holdings Limited (GH), a Dubai International Financial Centre-based multi-strategy private investment holding company, and NewOak Capital LLC, a New York collateralized private debt asset management and structured financing and capital markets firm, today announced the formation of Common Commodities CMXG (CMXG), a vertically integrated tech-enabled commodities investment platform designed to deliver risk-controlled, scalable institutional commodity-linked real yield and growth equity to qualified global investors. The partnership combines General Holdings' strategic capital and governance expertise with NewOak Capital's structured asset-based supply-chain financing capabilities and distribution platform. This sets the foundation for "a globally scalable, integrated and transparent institutional trade finance platform facilitating sustainable and inclusive cross-regional growth." Strategic Capital Deployment and Fund Launch CMXG
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom